Iright
BRAND / VENDOR: Biolegend

Biolegend, 100220, PE/Cyanine7 anti-mouse CD3 Antibody, 100μg

CATALOG NUMBER: 100220
Precio habitual$0.99
/
Los gastos de envío se calculan en la pantalla de pagos.
  • In stock, ready to ship

  • Pedido pendiente, envío pronto

Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.

Product Description

CD3, also known as T3, is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3 is composed of CD3ε, δ, γ and ζ chains. It forms a TCR complex by associating with TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: γδTCR-positive T-T hybridoma D1
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Additional reported application (for relevant formats) include: spatial biology (IBEX)1,2.
Application References(PubMed link indicates BioLegend citation): Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed Ho J, et al. 2016. PLoS Biol. 14:e2000117. PubMed Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed Sanmarco LM, et al. 2022. Nature. 611:801. PubMed Barsheshet Y, et al. 2022. Int J Mol Sci. 23:. PubMed Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed Sakae H, et al. 2023. Cells. 12:. PubMed Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed Zhang YT, et al. 2023. Front Immunol. 14:1085456. PubMed Bhaskar A, et al. 2023. iScience. 26:106644. PubMed Wang Y, et al. 2023. iScience. 26:106630. PubMed Nguyen T, et al. 2023. Nat Commun. 14:3357. PubMed Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed Millar FR, et al. 2022. Cell Rep. 41:111596. PubMed Tran TA, et al. 2022. Front Immunol. 13:1007285. PubMed Lee CY, et al. 2022. J Invest Dermatol. :. PubMed Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed Ryan CB, et al. 2022. Neurobiol Dis. 163:105608. PubMed Georgiev GI, et al. 2022. Cell Chem Biol. 29:811. PubMed Xiao R, et al. 2022. J Immunol. 208:2109. PubMed Ramdas B, et al. 2022. Mol Ther. 30:2505. PubMed Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed Schneider C, et al. 2018. Cell. 174:271. PubMed Page N, et al. 2018. Immunity. 48:937. PubMed Vacca M, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01462. PubMed Xiao C, et al. 2021. Front Pharmacol. 12:721273. PubMed Qi Z, et al. 2022. Nat Commun. 13:182. PubMed d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed Pan Y, et al. 2021. Front Cell Neurosci. 15:664312. PubMed Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed Chen S, et al. 2022. Cancer Discov. :. PubMed Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed Liang Y, et al. 2020. J Immunol. 204:2984. PubMed Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed Feizi N, et al. 2021. Cell Death Dis. 12:1026. PubMed Patnode M, et al. 2013. J Biol Chem. 288:26533. PubMed Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed Inoue D, et al. 2021. Nat Genet. 53:707. PubMed Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed Tian X, et al. 2022. Front Immunol. 13:875236. PubMed Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed Dieterich LC, et al. 2019. International Journal of Cancer. 145(10):2804-2815. PubMed Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed Campana L, et al. 2018. J Immunol. 200:1169. PubMed Green CD et al. 2018. Developmental cell. 46(5):651-667 . PubMed Jia L, et al. 2022. Front Immunol. 13:897879. PubMed Wang C, et al. 2021. Cell Rep. 37:110021. PubMed Mooney J, et al. 2015. Sci Rep. 5: 14603. PubMed Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed Chen D, et al. 2020. Cancer Immunol Res. 8:883. PubMed Taube C, et al. 2011. PLoS One. 6:e21799. PubMed Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed Garcia LR, et al. 2021. Nat Commun. 12:3364. PubMed Mulas F, et al. 2020. Cell Mol Immunol. . PubMed Kishore M et al. 2017. Immunity. 47(5):875-889 . PubMed Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed Hu Y, et al. 2022. J Nanobiotechnology. 20:417. PubMed Ullah I, et al. 2021. Immunity. 54:2143. PubMed Bergin SM, et al. 2021. Brain Behav Immun. 95:477. PubMed Luo J, et al. 2022. J Nanobiotechnology. 20:228. PubMed Kulkarni R, et al. 2021. PLoS One. 16:e0257191. PubMed Reinfeld BI, et al. 2021. Nature. 593:282. PubMed Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed Li Z, et al. 2018. Front Immunol. 9:347. PubMed LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed De Veirman K, et al. 2021. Oncoimmunology. 10:2000699. PubMed Jiang Y, et al. 2020. Adv Mater. 32:e2001808. PubMed Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed M H, et al. 2016. Sci Rep. 6: 20588. PubMed Song P, et al. 2018. Int J Mol Med. 41:935. PubMed Yazlovitskaya EM, et al. 2021. J Cell Sci. 134:. PubMed Yang R, et al. 2022. J Adv Res. 35:259. PubMed Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed Spix B, et al. 2022. Nat Commun. 13:318. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed Marcandalli J et al. 2019. Cell. 176(6):1420-1431 . PubMed Chen Z, et al. 2019. Mol Med Rep. 19:3210. PubMed Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed Li E, et al. 2021. Front Immunol. 12:667177. PubMed Glasenapp A, et al. 2021. Circ Res. 129:369. PubMed Haase P, et al. 2020. Eur J Immunol. 50:558. PubMed Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed Akoolo L, et al. 2021. Cell Microbiol. 23:e13350. PubMed Yin X, et al. 2020. Cell Rep. 33:108278. PubMed Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed Eastman AE, et al. 2020. Cell Rep. 31:107804. PubMed Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed Carson W, et al. 2011. PLoS One. 6:e20385. PubMed Spevak CC, et al. 2020. Cell Stem Cell. 26(5):755-765. PubMed Li H, et al. 2022. iScience. 25:104481. PubMed Catrysse L, et al. 2021. Cell Rep. 36:109748. PubMed Song X, et al. 2022. Transl Oncol. 15:101306. PubMed Tseng SH, et al. 2021. J Biomed Sci. 28:63. PubMed Hohsfield LA, et al. 2021. Elife. 10:. PubMed
RRID: AB_1732068 (BioLegend Cat. No. 100219) AB_1732057 (BioLegend Cat. No. 100220)
Structure: Ig superfamily, CD3/TCR, 20 kD
Distribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells
Function: Antigen recognition, TCR signal transduction, T cell activation
Ligand/Receptor: Peptide antigen/MHC-complex
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.
Gene ID: 12502
UniProt: View information about CD3 on UniProt.org
Clone: 17A2
Regulatory Status: RUO
Other Names: T cell antigen receptor complex, T3
Isotype: Rat IgG2b, κ


Order Guidelines

1. Price & Stock Available on Request. 📧Click to send email to: service@iright.com

2. Please DO NOT make payment before confirmation.

3. Minimum order value of $1,000 USD required.

Collaboration

Tony Tang

📧Email: Tony.Tang@iright.com

📱Mobile/WhatsApp/Wechat: +86-17717886924